SCYX
SCYNEXIS, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$5.31
−0.65%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 40.56x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.79x
- Price / sales
- 2.75x
- Price / cash flow
- -3.97x
Enterprise value
- Enterprise value
- $694.4K
- EV / sales
- 0.04x
- EV / EBITDA
- -0.07x
- EV / EBIT
- -0.03x
- Market cap
- $52.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026